SK281137B6 - Spôsob prípravy pyridínových derivátov, ich použitie a medziprodukty na ich prípravu - Google Patents

Spôsob prípravy pyridínových derivátov, ich použitie a medziprodukty na ich prípravu Download PDF

Info

Publication number
SK281137B6
SK281137B6 SK42-93A SK4293A SK281137B6 SK 281137 B6 SK281137 B6 SK 281137B6 SK 4293 A SK4293 A SK 4293A SK 281137 B6 SK281137 B6 SK 281137B6
Authority
SK
Slovakia
Prior art keywords
group
formula
compound
tert
nhy
Prior art date
Application number
SK42-93A
Other languages
English (en)
Slovak (sk)
Other versions
SK4293A3 (en
Inventor
L�Szlo R�V�Sz
Rudolf Waelchli
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SK4293A3 publication Critical patent/SK4293A3/sk
Publication of SK281137B6 publication Critical patent/SK281137B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Soft Magnetic Materials (AREA)
  • Paper (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK42-93A 1992-01-31 1993-01-28 Spôsob prípravy pyridínových derivátov, ich použitie a medziprodukty na ich prípravu SK281137B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929202139A GB9202139D0 (en) 1992-01-31 1992-01-31 Improvements in or relating to organic compounds

Publications (2)

Publication Number Publication Date
SK4293A3 SK4293A3 (en) 1993-11-10
SK281137B6 true SK281137B6 (sk) 2000-12-11

Family

ID=10709643

Family Applications (1)

Application Number Title Priority Date Filing Date
SK42-93A SK281137B6 (sk) 1992-01-31 1993-01-28 Spôsob prípravy pyridínových derivátov, ich použitie a medziprodukty na ich prípravu

Country Status (16)

Country Link
EP (1) EP0556152B1 (hu)
JP (1) JP3544549B2 (hu)
AT (1) ATE210645T1 (hu)
AU (1) AU663909B2 (hu)
CA (1) CA2088396A1 (hu)
CZ (1) CZ288038B6 (hu)
DE (1) DE69331293T2 (hu)
DK (1) DK0556152T3 (hu)
ES (1) ES2169723T3 (hu)
FI (1) FI104896B (hu)
GB (1) GB9202139D0 (hu)
HU (1) HU214677B (hu)
NO (1) NO180779C (hu)
PT (1) PT556152E (hu)
SG (1) SG43065A1 (hu)
SK (1) SK281137B6 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620861A (en) * 1992-07-31 1997-04-15 Metra Biosystems, Inc. Method and kit for pyridinium crosslink assay
US5756361A (en) * 1992-12-17 1998-05-26 Metra Biosystems, Inc. Screening method for periodontal disease
US5736344A (en) * 1992-12-17 1998-04-07 Metra Biosystems, Inc. Serum pyridinium crosslinks assay
US5661039A (en) * 1995-03-01 1997-08-26 Metra Biosystems, Inc. Perspiration assay for bone resorption
US5723619A (en) * 1997-01-13 1998-03-03 Bayer Corporation Method for the synthesis of deoxypyridinoline
US5834610A (en) * 1997-05-06 1998-11-10 Johnson; Gary M. Conversion of pyridinoline to deoxypyridinoline
CN105801688A (zh) * 2016-04-14 2016-07-27 苏州博源医疗科技有限公司 脱氧吡啶酚免疫原、抗体和检测试剂及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59148766A (ja) * 1983-02-10 1984-08-25 Otsuka Pharmaceut Co Ltd ピリジン誘導体
US4973666A (en) * 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
GB8929366D0 (en) * 1989-12-30 1990-02-28 Rowett Research Inst Method to detect connective tissue disorder in humans and animals

Also Published As

Publication number Publication date
NO930284L (no) 1993-08-02
HU214677B (hu) 1998-04-28
HU9300108D0 (en) 1993-04-28
ATE210645T1 (de) 2001-12-15
NO180779C (no) 1997-06-18
DE69331293T2 (de) 2002-07-18
EP0556152A1 (en) 1993-08-18
CZ288038B6 (cs) 2001-04-11
FI104896B (fi) 2000-04-28
PT556152E (pt) 2002-05-31
EP0556152B1 (en) 2001-12-12
HUT70276A (en) 1995-09-28
AU3210593A (en) 1993-08-05
NO930284D0 (no) 1993-01-28
AU663909B2 (en) 1995-10-26
NO180779B (no) 1997-03-10
SK4293A3 (en) 1993-11-10
JPH0641078A (ja) 1994-02-15
GB9202139D0 (en) 1992-03-18
JP3544549B2 (ja) 2004-07-21
DK0556152T3 (da) 2002-04-08
DE69331293D1 (de) 2002-01-24
CA2088396A1 (en) 1993-08-01
FI930367A0 (fi) 1993-01-28
ES2169723T3 (es) 2002-07-16
SG43065A1 (en) 1997-10-17
FI930367A (fi) 1993-08-01
CZ10693A3 (en) 1993-12-15

Similar Documents

Publication Publication Date Title
US5688921A (en) Reagents and methods for the detection and qualification of thyroxine in fluid samples
US5593896A (en) Reagents and methods for the detection and quantification of thyroxine in fluid samples
CA2769998C (en) Imatinib immunoassay
DE102011055265A1 (de) Automatenfähiger Immunoassay für biogene Amine
SK281137B6 (sk) Spôsob prípravy pyridínových derivátov, ich použitie a medziprodukty na ich prípravu
US6140137A (en) Conjugates and specific immunoassays for the methadone metabolite 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine
US20100240137A1 (en) Derivatization-enhanced analysis of amino acids and peptides
JP2732825B2 (ja) 新規なベンゾジアゼピン−タンパク質結合体
Adamczyk et al. Synthesis of immunocomponents for the measurement of lead (Pb) by fluorescence polarization immunoassay
EP2418492B1 (en) Immunoreagent for meprobamate
US20080050827A1 (en) Derivatization-enhanced analysis of amino acids and peptides
US6175016B1 (en) Pyridine derivatives
US6291198B1 (en) Antibody that recognizes pyrazine derivative and method for measuring 1,2-dicarbonyl derivative using said antibody
US20050037423A1 (en) Isotopycally coded affinity marker 2
US5824786A (en) Synthesis of galactosylhydroxylysine
JP3508563B2 (ja) ピラジン誘導体認識抗体及びそれを用いた1,2−ジカルボニル誘導体の測定方法
DeMarco et al. Lisinopril
JPH04264069A (ja) ビリルビン誘導体